Article
Frailty in patients with IDH-mutant gliomas: experience from a high-volume tumor center.
Journal of neuro-oncology - 1 Jul 2024
Bray David P, Stubbs Nolan M, Chow Jocelyn, Jahangiri Arman, Nduom Edjah K, Olson Jeffrey J, Hoang Kimberly B
Abstract excerpt
PURPOSE: Gliomas are increasingly diagnosed in an aging population, with treatment outcomes influenced by factors like tumor genetics and patient frailty. This study focused on IDH-mutant gliomas and assessed how frailty affects 30-day readmission and overall survival (OS). We aimed to address a gap in understanding the impact of frailty on this specific glioma subtype. METHODS: 136 patients with an IDH-mutant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
